Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China · Delayed Price · Currency is CNY 66.38
+4.37 (7.05%)
At close: Mar 27, 2026
SHA:688513 Market Cap
SHA:688513 has a market cap or net worth of 11.57 billion as of March 27, 2026. Its market cap has increased by 117.27% in one year.
Market Cap
11.57B
Enterprise Value
10.14B
Revenue
1.33B
Ranking
n/a
PE Ratio
40.72
Stock Price
66.38
Market Cap Chart
Since September 2, 2020, SHA:688513's market cap has increased from 8.97B to 11.57B, an increase of 28.98%. That is a compound annual growth rate of 4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 11.57B | 7.85% |
| Dec 31, 2025 | 10.73B | 104.34% |
| Dec 31, 2024 | 5.25B | -31.43% |
| Dec 29, 2023 | 7.66B | 4.83% |
| Dec 30, 2022 | 7.31B | 31.12% |
| Dec 31, 2021 | 5.57B | -2.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 13.26B |
| Tibet Cheezheng Tibetan Medicine | 13.02B |
| Chengzhi | 12.65B |
| Pacific Shuanglin Bio-pharmacy | 12.47B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.15B |
| Chengdu Olymvax Biopharmaceuticals | 12.07B |
| Beijing Hotgen Biotech | 11.74B |
| InventisBio | 11.56B |